prospective trial to evaluate the effect of nebulized vancomycin in children with cystic fibrosis
Not Applicable
- Conditions
- Health Condition 1: E840- Cystic fibrosis with pulmonary manifestations
- Registration Number
- CTRI/2020/06/025699
- Lead Sponsor
- Jagat Jeevan Ghimire
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children of cystic fibrosis with early Staphylococcus aureus infection.Early infection defined as a positive culture in current culture or culture within 6 months that was not treated on prior visits which may be either the first-lifetime positive culture or new emergence of the organism after at least 1 year of documented negative cultures
Exclusion Criteria
1.Children with Current Co-colonisation with pseudomonas spp.
2.Children receiving anti-staphylococcal treatment in 4 weeks prior to screening and enrolment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method